COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,612 Articles (22,913 medRxiv, 8,699 bioRxiv)

Most recent first Previous |  Page 1958: Articles 19571-19580  | Next

Augmented curation of clinical notes of COVID-19 and influenza patients reveals that long-term neuropsychiatric and coagulopathic symptoms are more associated with COVID-19
Soundararajan, V., Awasthi, S., Martin, J. T., Akama-Garren, E., Puranik, A., Liukasemsarn, S., Venkatakrishnan, A. J., O'Horo, J. C., Hurt, R. T., Williams, A. W., Gores, G. J., Halamka, J., Badley, A. D.
10.1101/2021.01.03.20248997 — Posted: 2021-01-05
OPTIMIZING COVID-19 VACCINE USAGE
P Jara, C., Velloso, L., Pereira de araujo, E.
10.1101/2021.01.04.21249167 — Posted: 2021-01-05
Prediction of confirmed and death cases of Covid-19 in Chile through time series techniques: A comparative study
Barria-Sandoval, C., Ferreira, G., Benz-Parra, K., Lopez-Flores, P.
10.1101/2020.12.31.20249085 — Posted: 2021-01-05
Empty Streets, Speeding and Motor Vehicle Collisions during Covid-19 Lockdowns: Evidence from Northern Ireland
Vandoros, S., Papailias, F.
10.1101/2021.01.03.21249173 — Posted: 2021-01-05
Optimizing testing for COVID-19 in India
Cherian, P., Krishna, S., Menon, G. I.
10.1101/2020.12.31.20249106 — Posted: 2021-01-05 Discussion: Onsite
Hospitalization as reliable indicator of second wave COVID-19 pandemic in eight European countries
Allieta, M., Rossi Sebastiano, D.
10.1101/2020.12.31.20249084 — Posted: 2021-01-05
Syncope and COVID-19 disease - a systematic review.
Falcao de Freitas, R., Torres, S. C., Nunes, J. P. L.
10.1101/2020.12.30.20249060 — Posted: 2021-01-05
The impact of COVID-19 vaccination campaigns accounting for antibody-dependent enhancement
Adil M. Y., N., Tsoungui Obama, H. C. J., Ngucho Yvan Mbeutchou, J., Kwamou Ngaha, S. F., Kayanula, L., Kamanga, G., Ibrahim, T. B., Bwanu Iliya, P., Iyanda, S. B., Alawam Nemer, L. H. M., Helle, K. B., Teboh-Ewungkem, M. I., Schneider, K. A.
10.1101/2021.01.04.425198 — Posted: 2021-01-04 Discussion: Onsite
TMPRSS2 structure-phylogeny repositions Avoralstat for SARS-CoV-2 prophylaxis in mice
Sun, Y. J., Velez, G., Parsons, D., Li, K., Ortiz, M., Sharma, S., McCray, P. B., Bassuk, A. G., Mahajan, V. B.
10.1101/2021.01.04.425289 — Posted: 2021-01-04
The SARS-CoV-2 antibody landscape is lower in magnitude for structural proteins, diversified for accessory proteins and stable long-term in children
Hachim, A., Gu, H., Kavian, O., Kwan, M. Y., Chan, W.-h., Yau, Y. S., Chiu, S. S., Tsang, O. T., Hui, D. S., Ma, F., Lau, E. H., Cheng, S. M., Poon, L. L., Peiris, M. J., Kavian, N., Valkenburg, S. A.
10.1101/2021.01.03.21249180 — Posted: 2021-01-04

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).